Mapping Biopsy Procedure on Management of Severe Buruli Ulcer Due to Mycobacterium ulcerans, Subspecies shinshuense
Report of a Case | A healthy male teenager presented with a 2-month history of eruptions on the dorsum of his left hand, which showed diffuse painful erythema and a 2-cm ulcer. Results of blood tests were normal but for slightly elevated Creactive protein levels (0.46 mg/dL). Culture results from the ulcer were negative for any general bacteria. Computed tomography showed neither gas production nor abscess formation. Histologic examination of the erythematous lesion revealed diffuse necrosis, and Ziehl-Neelsen (Z-N) staining showed many acid-fast bacilli in the subcutis. We diagnosed cutaneous mycobacterial infection.
Despite treatment with oral clarithromycin, 800 mg/d, and levofloxacin, 500 mg/d, the lesion expanded. Therefore rifampicin, 450 mg/d, was added to the treatment regimen 7 days after the initiation of therapy. We performed debridement on day 8 (Figure, A) . Although almost all the skin on the dorsum of his hand was debrided, the erythema further expanded. We performed a second debridement on day 25 and additionally excised the erythematous lesion toward the wrist, including the area labeled 8 in Figure, B, and debrided necrotic tissue. The lesion rapidly improved after the second debridement, although some finger extensor tendons gradually became necrotic, and reconstruction of tendons was needed. The patient showed no recurrence at 1-year follow-up.
At 4 weeks, growth of a yellow-white colony in Ogawa egg medium was observed. Analysis using DNA-DNA hybridization (Kyokuto, Japan) demonstrated Mycobacterium marinum bacteria. Polymerase chain reaction (PCR) analysis targeting insertion sequence IS2404 1,2 and pathogenic plasmid MUM001 gene sequences 3 revealed Buruli ulcer caused by Mycobacterium ulcerans subspecies shinshuense, a rare mycobacterium phenotypically close to M ulcerans that produces a toxin resembling mycolactone. 3, 4 We note that M ulcerans subspecies shinshuense can also affect tendons and muscles, as in our case and at least 1 other case. 5 Recommendations concerning the duration of antibiotic treatment and timing of surgical intervention for Buruli ulcer have been offered in preliminary guidelines issued by the World Health Organization, but there is no reliable evidence to determine the extent of surgical excision.
Discussion | Using a 3-mm punch, we performed multiple biopsies from 13 erythematous sites on our patient's hand and wrist ( Figure (Table) . From the clinical course, we determined that all sites of first debridement (samples 1-6) and the area around sample 8 of the second debridement needed surgical resection. We performed the second debridement to address severe postoperative functional limitations and in- flammation found on visual inspection, and significant improvement was achieved, even though other erythematous lesions were not surgically removed. The histologic findings from H-E staining could be roughly categorized into 2 patterns: necrosis without granuloma formation ( Figure, E ) and granuloma formation without necrosis (Figure, F) . The sites that needed resection were not related to the results of Z-N staining or PCR analysis for IS2404 but instead to the histologic features of cutaneous necrosis without granuloma formation. We speculate that skin erythematous lesions with histologic granuloma formation can possibly be spared from surgical excision, and erythematous lesions with persistent histologic necrosis should be excised. A, Clinical presentation just before first debridement: diffuse erythema and swelling on the dorsum of the left hand and necrotic skin ulcer on the lateral edge of the hand were observed; biopsies were performed at sites from 1 through 6 around the ulcer. B, Clinical presentation before second debridement: biopsies from the erythematous lesions were performed at sites 7 and 8. C, Clinical presentation before second debridement; biopsies from the erythematous lesions were performed at sites 9 and 10. D, Clinical presentation before second debridement: biopsies from the erythematous lesions were performed at sites 11 through 13. E, Histological findings from site 8: significant necrosis without granulomatous reaction was observed (hematoxylin-eosin, original magnification ×100). F, Histologic findings from site 10 showed granulomatous reactions without necrosis (hematoxylin-eosin, original magnification ×100). G, Results of polymerase chain reaction (PCR) analysis for IS2404 using pu4f and pu7r primers. Samples 1, 2, 4, 5, 6, and 11 tested positive for IS2404. Gene markers 1 through 13 represent biopsy samples taken from sites 1 through 13, respectively; gene marker N, normal control; gene marker D, 100-bp DNA marker. Abbreviations: H-E, hematoxylin-eosin stain; PCR, polymerase chain reaction; Z-N, Ziehl-Neelsen; +, positive finding; −, negative finding. a Results of PCR analysis for IS2404 and histologic examination with Z-N staining and H-E staining of all mapping biopsy samples taken before first debridement (sites 1-6) and before second debridement (sites 7-13).
